This enzyme is called cytochrome P450 1A2 (CYP1A2)
(1993) Fats show business
That said, weight loss in people with diabetes is still clinically meaningful and often leads to: Improved glucose control Reduced medication requirements Lower cardiovascular risk Better energy levels and mobility Important considerations GLP-1 medications are not cosmetic weight-loss drugs
Effects of GLP-1RAs on HF On the whole, meta-analyses have shown that GLP-1RAs reduced the risk of developing HF ( HR = 0.62, 95% CI 0.311.02) [89]

BPC-157: The Angiogenic Healer BPC-157's healing effects center on blood vessel formation and cytoprotection: VEGF Upregulation: Increases vascular endothelial growth factor, promoting new blood vessel formation to injured tissues (PMID: 27847966, PMID: 40789979) Nitric Oxide System: Modulates NO pathways, protecting tissues from oxidative damage and improving blood flow (PMID: 31158953) Growth Factor Pathways: Interacts with and functionally engages growth-factordependent cytoprotective and regenerative pathways, producing growth-factorlike effects (PMID: 11718984, PMID: 40789979) Cytoprotective: Protects cells from various toxic insults including NSAIDs, alcohol, and ischemia (PMID: 31158953) Nerve Healing: BPC-157 indirectly modulates GABAergic inhibitory control, supporting nerve regeneration (PMID: 15840402) TB-500: The Cell Migration Facilitator TB-500 is a synthetic peptide designed to mimic Thymosin -4, which is well-established in actin sequestration, cell migration, wound repair, and anti-inflammatory signaling

It is a glucagon-like peptide-1 (GLP-1) receptor agonist that is administered once a week through injection